Trillium Therapeutics (Canada)
- Research works
- 61 ▲ 24% vs 2013–17
- Citations
- 1.1k 17.7 per fractional work
- Top-10% rate
- 16.8% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: Trillium Therapeutics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 24.9×. Every wedge is a field page.
- Immunology and Microbiology 24.9×
- Medicine 2.6×
- Neuroscience 2.2×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Physics and Astronomy 0.8×
- Decision Sciences 0.7×
- Psychology 0.7×
- Health Professions 0.5×
- Computer Science 0.4×
- Business, Management and Accounting 0.4×
- Economics, Econometrics and Finance 0.4×
- Engineering 0.2×
- Social Sciences 0.1×
- Environmental Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Materials Science 0.1×
Which keywords describe research at Trillium Therapeutics (Canada)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Ethical Considerations, Transplantation, Macrophages, Immune Regulation, Kidney Transplantation, apoptotic cells and CD47.
- Rejection
- End-of-Life
- Antigen Presentation
- Gene Therapy
- CAR T Cells
- TGF-ß
- Immunosuppressive Therapy
- Biliary Complications
- Macrophage
- Activation
- Immunotherapy
- Metabolism
- NK Cell Recognition
- Graft Survival
- Living Kidney Donors
- Immunity
- CD47
- Immune Regulation
- Transplantation
- Inflammation
- Cancer Immunotherapy
- Ethical Considerations
- Macrophages
- Kidney Transplantation
- apoptotic cells
- Cancer
- Organ Donation
- Innate Immunity
- Natural Killer Cells
- Ischemia-Reperfusion Injury
- Tumor Regression
- Liver Transplantation
- Autoimmunity
- Donor Risk Index
- Foxp3
- Lymphoma
- Chimeric Antigen Receptor
- Health Care Costs
- Dendritic Cells
- Palliative Care
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Immunotherapy7▲ 81×3 topics
- Inflammation5▲ 3.6×16 topics
- Ethical Considerations5▲ 24×3 topics
- Transplantation4▲ 64×3 topics
- Macrophages4▲ 42×2 topics
- Immune Regulation4▲ 52×2 topics
- Kidney Transplantation4▲ 98×2 topics
- CD474▲ 433×1 topic
- apoptotic cells4▲ 433×1 topic
- Immunity4▲ 18×4 topics
- Cancer3▲ 3.8×8 topics
- Living Kidney Donors3▲ 185×1 topic
- Organ Donation3▲ 185×1 topic
- Graft Survival3▲ 48×2 topics
- Innate Immunity3▲ 14×4 topics
- NK Cell Recognition3▲ 45×1 topic
- Natural Killer Cells3▲ 45×1 topic
- Metabolism3▲ 6.6×3 topics
- Ischemia-Reperfusion Injury2▲ 42×2 topics
- Immunotherapy2▲ 5.8×3 topics
- Tumor Regression2▲ 43×2 topics
- Activation2▲ 105×1 topic
- Liver Transplantation2▲ 24×2 topics
- Macrophage2▲ 65×1 topic
- Autoimmunity2▲ 16×2 topics
- Biliary Complications2▲ 62×1 topic
- Donor Risk Index2▲ 62×1 topic
- Immunosuppressive Therapy2▲ 17×5 topics
- Foxp32▲ 41×1 topic
- TGF-ß2▲ 18×1 topic
- Lymphoma2▲ 20×2 topics
- CAR T Cells2▲ 61×1 topic
- Chimeric Antigen Receptor2▲ 61×1 topic
- Gene Therapy2▲ 9.5×3 topics
- Health Care Costs2▲ 31×2 topics
- Antigen Presentation1▲ 23×2 topics
- Dendritic Cells1▲ 20×2 topics
- End-of-Life1▲ 28×1 topic
- Palliative Care1▲ 14×1 topic
- Rejection1▲ 45×2 topics
Which research topics does Trillium Therapeutics (Canada) publish most on?
By volume in 2022–2025: Organ Donation and Transplantation, T-cell and B-cell Immunology, Immune Cell Function and Interaction and Palliative Care and End-of-Life Issues.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Organ Donation and Transplantation Public Health, Environmental and Occupational Health 1 works
- 2 T-cell and B-cell Immunology Immunology 1 works
- 3 Immune Cell Function and Interaction Immunology 1 works
- 4 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 1 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 6 Organ Transplantation Techniques and Outcomes Surgery 0 works
- 7 Phagocytosis and Immune Regulation Immunology 0 works
- 8 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 0 works
- 9 Treatment of Major Depression Pharmacology 0 works
- 10 Chemokine receptors and signaling Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Trillium Therapeutics (Canada)'s research output changed?
Output in 2018–2022 was 24% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Toronto
- University of Toronto
- York University
- Hospital for Sick Children
- Toronto Metropolitan University
- University Health Network
- Sunnybrook Health Science Centre
- St. Michael's Hospital
- Princess Margaret Cancer Centre
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.